Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...
MUMBAI, Feb 17 (Reuters) - Drug firm Wockhardt Ltd on Tuesday said it will be launching Sumatriptan injections in the U.S. following following final approval from the U.S. Food & Drug Administration.
Tosymra (sumatriptan) is a brand-name drug that’s prescribed to treat migraine with or without aura in adults. Tosymra comes as a nasal spray that’s used when needed to manage a migraine episode.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results